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The nature of the blast cells in acute myeloblastic leukemia (AML) ~ has been 
examined extensively at the level of the phenotype. Morphology, using standard 
staining procedures such as Wright-Giemsa, is now supplemented with histochem- 
ical  (1)  or  immunological  methods  (2-4)  that  detect  markers  associated  with 
developmental  stage  or  lineage.  Morphological  studies  usually disclosed blasts 
that were homogeneous within each patient, although sufficient patient-to-patient 
variation  was detected to provide a  basis for the  FAB classification  (5).  These 
observations were consistent with a view of AML similar to the blocked differ- 
entiation  hypothesis  developed from  analysis  Of blasts  in  acute  lymphoblastic 
leukemia (ALL) (6). In contrast, studies of chemically or immunologically defined 
markers revealed striking heterogeneity.  In addition to markers associated with 
immaturity,  such as HLA-DR (7), markers of the three lineages of myelopoiesis 
were encountered regularly. In some instances, lymphoid differentiation markers 
were found (8) in AML blasts. 
The most complex phenotypes were those where markers of more than  one 
lineage were detected simultaneously in  individual  blast cells (8-11).  We have 
called this phenotype lineage infidelity (9),  using the term  to contrast with the 
concept that differentiation programs are followed faithfully in blast cells until 
some block is reached. We preferred this view over one that postulated biclonal 
disease,  since,  where  genetic  markers  of clonality  have  been  used,  AML was 
found to be predominantly clonal (12). 
Regardless of the interpretation,  phenotypic studies are limited by the speci- 
ficity and sensitivity of the reagents used to define markers.  It is now feasible to 
examine  leukemic blasts at the level of the genome.  In both B cell and T  cell 
malignancies,  gene  rearrangements  have been  found  (13-15)  similar  to  those 
that are considered to be first steps in  the expression of Ig or T  cell receptor 
(TCR) proteins.  Further I g gene rearrangements have been reported (16) in cell 
lines considered to be of myeloid origin. These genetic methods have advantages 
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over  phenotypic  markers;  their  lineage  specificity  is  widely  accepted,  and  in 
addition, they provide evidence of clonality (14). 
In this paper we report findings in blasts from 24 AML patients.  DNA from 
the cells was probed with cDNA from the/3 chain of TCR and Ig H  and L chain 
probes. In three instances, rearrangements of the TCR were detected.  Blasts of 
one of these patients also had Ig chain gene rearrangements. 
Materials and  Methods 
Patient Population 
Peripheral  blood samples were collected from 24  patients with a  diagnosis of AML 
based on conventional morphological and cytochemical criteria. The clinical characteristics 
of these patients were similar to those for other series from this institution (17,  18). The 
morphological classifications include FAB class 1-6, a mean age of 53.4 (median 53, range 
18-82); a  mean peripheral blast count of 34,700  X  106 per liter (median 28,000  range 
120-250,000).  Blast cell phenotypes were determined as described by Smith et al. (9); the 
mAb My-906, a  kind gift from Dr.  Griffin of Dana  Farber Institute,  Boston,  MA was 
added to the panel of immunological reagents. This antibody detects an antigen associated 
with granulopoietic differentiation (19).  As in other studies (8-11) there was a  marked 
patient-to-patient and blast-to-blast phenotypic variation. Single cells simultaneously ex- 
pressing markers of more than one lineage were detected in 8 of 24 patients. 
DNA from the blasts of three patients was not in germline configuration. The clinical 
features and blast cell characteristics of these three patients are summarized below. 
Patient 1.  A 66-y-old man presented with increasing shortness of breath. The hema- 
tological findings on admission were: hemoglobin, 94 g/liter; white blood cells,  375,000 
x  106 per liter (80% blasts); platelet count,  76,000  x  106 per liter. The blast cells were 
considered  M4;  they were peroxidase positive (30%),  esterases positive (25%), and ex- 
pressed My-1 (18%), OKM 1 (38%), MO2 (35%), My-906 (71%), or spectrin (1%). Doubly- 
marked cells (0.3%) were present, simultaneously expressing spectrin and My-906. The 
blast cells were not positive for T  cell-associated surface markers or terminal deoxynucle- 
otide transferase. Surface and cytoplasmic Ig were absent. The patient underwent leuka- 
pheresis but died within several hours of admission with extensive pulmonary and central 
nervous system leukemic infiltration. 
Patient 2.  A 66-y-old man presented with 4-mo history of pancytopenia and recurrent 
sore throat. On admission, the hematological findings were: hemoglobin, 84 g]liter; white 
blood cells,  2,800 x  10  6 per liter (8% blasts); platelets, 45,000  x  106 per liter. The bone 
marrow was hypercellular, with 42% blasts. The erythroid precursors were bizarre with 
megaloblastic and binucleate cells.  The blast cells were considered M6; they were myelo- 
peroxidase positive and expressed My-906 (6%), MO2 (9%), spectrin (19%), OKT3 (0.5%) 
and OKT8 (0.5%). Doubly-marked cells (0.1%) were detected expressing simultaneously 
spectrin  and  MO2,  and  spectrin  and  OKT8.  This patient  was treated  with  high-dose 
cytosine arabinoside according to the protocol now under test in this Institute (20,  21). 
He died 2 mo later with septicemia without achieving a remission. 
Patient 3.  A 66-y-old woman presented with sore throat. On admission, the hemato- 
logical findings were:  hemoglobin,  99  g/liter;  white blood cells,  2,700  x  106 per liter 
(64% blasts);  platelets, 236,000 x  106 per liter. The marrow was hypercellular, with 74% 
blasts.  The  blast  cells  were  considered  MI.  They were  myeloperoxidase positive and 
expressed My-7 (63%), My-906 (39%), and terminal deoxynucleotide transferase (13%). 
Doubly-marked cells (1.5%) were present, simultaneously expressing terminal deoxynu- 
cleotide transferase and My-7. The cells were not positive for T  cell-associated surface 
antigens or surface and cytoplasmic Ig. The patient was treated with high-dose cytosine 
arabinoside. She died 6 mo later without ever achieving a complete remission. 
Southern  Blot Analysis 
A T cell-depleted, blast cell-enriched fraction was obtained from each peripheral blood 
sample by the two-stage procedure described previously (22).  DNA was extracted from 416  T  CELL  RECEPTOR  AND  Ig GENE  REARRANGEMENTS 
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FIGURE  l.  Schematic  representation of the relationship  of the hybridization  region (white 
box) of the 3-C probe to 3-TCR DNA. The probe reacts  with both Cj and C2 regions.  As 
deduced from the restriction  sites shown,  this  probe will detect a single  23.5  kb band in 
germline DNA digested  with Barn HI and two bands,  11 and 4 kb, respectively, with Eco RI 
digestion. The hatched box shows the relationship  of the JC2 probe to 3-TCR DNA. 
these  populations  by proteinase  K  digestion  and  phenol/chloroform  extraction.  Each 
DNA sample (10 #g) was digested with 50 U of the restriction enzymes Barn HI and Eco 
RI in appropriate buffers at 37°C for at least 6 h to ensure complete digestion (23). The 
resulting DNA fragments were separated according to size by agarose gel (0.8%) electro- 
phoresis in 40 retool/liter Tris-acetate,  1 mmol/liter EDTA, pH 8.0. Hind III-digested 
phage DNA molecular weight markers were included on every gel. The sized-separated 
DNA fragments were transferred  from agarose gel to Genatran  filters  (Schleicher and 
Schuell,  Keene,  NH) as described  by Southern  (24).  The filters  were prehybridized  in 
solutions containing 50% (vol/vol) formamide, 5× SSC, 0.05 M NaH~PO4/Na~HPO4 (pH 
6.7), 5× Denhardt's, and 400 #g/ml sonicated salmon sperm DNA at 42°C for 12-18 h. 
DNA  on  Genatran  filters  was  hybridized  to  3eP-labeled  DNA probes  in  hybridization 
solutions consisting of 50%  (vol/vol) formamide,  5× SSC,  0.02  M  Na2HPO4/NaH2PO4 
(pH 6.7)  1× Denhardt's, and 200 #g/ml sonicated salmon sperm DNA at 42°C for 36- 
48  h.  The  filters  were  washed  to a  final  solution  of 0.1×  SSC at  65°C  for  1  h,  and 
autoradiographed at -70°C with an intensifying screen. 
Preparation of Labeled Probe DNA 
A  probe  (3-C)  was prepared  from TCR /3 chain  cDNA by nick-translating  a  0.2  kb 
cDNA Ava I-Eco RV fragment. This fragment contains the constant (C1) region of the 
/3-TCR gene,  and  crossreacts  with  the  second constant  region  (C2). The  hybridization 
regions of this probe to the  TCR  DNA are  shown schematically in  Fig.  1.  As may be 
deduced from the restriction sites shown in Fig. 1, this probe will detect a single 23.5 kb 
fragment in germline DNA digested with Bam HI (Fig. 2a, lanes 4 and 5).  With Eco RI 
digestion, the germline pattern consists of two bands, the  I 1 kb band represents the first 
constant region (C~), while the 4 kb band represents the second constant region (C2) (Fig. 
2 b, lane 4). 
The JC2 probe consists of a 4 kb Eco RI fragment of the j2 region. This probe detects 
a  4  kb  band  in  germline  DNA digested  with  Eco  RI  (Fig.  2c,  lane  3).  It is  useful  in 
analyzing rearrangement into the C~ region. 
The Ju probe consists of a  3 kb cloned Eco RI-Hind III fragment, which contains the 
J  region of the H  chain lg gene. In a Barn HI-digested germline DNA, this probe detects 
a single 18 kb band. 
The Ck probe is a  1 kb Eco RI fragment from the C region of the K L chain. This probe 
will detect a  12 kb band in germline configuration with Bam HI digestion. 
Northern Blot and Dot Blot Analyses 
RNA analysis was carried out on  RNA samples from patients whose DNA showed a 
rearranged configuration detected with one of the above probes. 
Total cellular RNA was extracted by guanidium thiocyanate/CsCl method (25).  10 ~g 
of each RNA sample was separated according to size by electrophoresis in  1.1% agarose 
gel.  The  size-separated  fragments  were  transferred  to  Genatran  filters  by  Northern 
techniques, prehybridized in solution containing 50% formamide (vol/vol), 5× SSC, 0.05 
M  Na~HPO4 (pH 6.7),  5× Denhardt's solution, and 400 #g/ml sonicated salmon sperm 
DNA,  and  hybridized  to radiolabeled  [3eP]DNA /3-C and  Ctt  probes  described  above, 
washed, and autoradiographed.  RNA from T  cell  lines (Jurkat)  and B cell line (RPMI- 
3638) were used as control. CHENG  ET  AL.  417 
FIGURE 2.  A, Barn HI digestion and hybridization to [s2Pl-labeled 13-C probe. Lane 1,  DNA 
from patient 3 consisted of a  single 23,5  kb band. Lane 2,  DNA from patient 2.  There is a 
27.0  kb band.  No germline band is detected.  Lane 3,  DNA  from patient  1.  The germline 
band is missing. There are two rearrangement bands; 17.5 and 16.5 kb, respectively. Lanes 4 
and 5,  Germline configuration consisting of a  single 23.5  kb band. B, Eco  RI digestion and 
hybridization to s~P-labeled fl-C probe.  Lane  1,  DNA from patient 3.  Two bands,  I /  and 4 
kb, were seen. The  11  kb band is less dense than the 4  kb band. Lane 2, DNA from patient 
1. The  11  kb band is missing, only the 4  kb band is detected.  Lane 3,  DNA from patient 2. 
No germline 11  kb band is detected. There is a 9 kb band in addition to the 4 kb band. Lane 
4,  Germline configuration consisting of two bands,  11  kb and 4  kb,  respectively. C,  Eco  RI 
digestion and hybridization to JCz probe.  Lane  1,  DNA from patient 3. The 4  kb germline 
band as well as a  rearranged 7.5 kb band were detected.  Lane 2,  DNA from patient 1. The 
germline band  is  missing.  Two  rearranged  bands,  6.0 and 5.5  kb,  were  detected.  Lane  3, 
Germline configuration consisting of a single 4 kb band. 
RNA samples obtained from  I0  ~, 5 ×  104, 2.5 X /04,  1.25 ×  10  ~, 0.6 x  104 patients' 
cells were spotted onto Genatran filters, prehybridized for 8-12 h, then hybridized  with 
[32P]DNA 13-C probe, washed, and autoradiograpbed. 
Cytogenetics 
Blast-enriched  populations were cultured in a-MEM with HTB9-conditioned medium 
(26) as a source of growth factor for 72 h (27). Chromosome harvests  were initiated  by 
incubation with colchicine (0.02 ug]ml) followed by treatment with hypotonic KCI (0.075 
M) and fixation  three times with  3:1  methanol/glacial  acetic acid. Chromosome spreads 
were prepared following standard methods, and identified  using trypsin G-banding  (28). 
Results 
t3- TCR Rearrangement 
DNA samples from  24 AML patients  were analyzed.  DNA samples from  22 
patients showed a  23.5 kb band with the 13-C probe and Barn HI digestion (Fig. 
2a,  lanes 4  and  5).  In  21  patients,  two bands,  11  and  4  kb, respectively, were 
seen  with  /3-C probe  and  Eco  RI  digestion  (Fig.  2b,  lane  4).  DNA  from  22 
patients,  digested  with  Eco  RI and  probed  with  the JC~ probe showed a  4  kb 
band (Fig. 2c, lane 3). Thus, in the blast cell DNA of 21 of 24 patients, convincing 
evidence of rearrangement  was not found. 
Patient  1.  DNA  from  this patient,  when  digested  with either Bam  HI  (Fig. 
2 a,  lane 3) or Eco R1 (Fig.  2 b, lane 2) and analyzed with/3-C probe was not in 
germline configuration.  The 23.5 kb germline band was missing in the Southern 
blot of the Barn  HI digest,  and  there  were two rearranged  bands of 17.5 and 
16.5 kb, respectively. This configuration suggests rearrangement of both/3-TCR 
loci. With Eco RI digestion, the 1 1 kb band corresponding to the C~ region was 418  T  CELL RECEPTOR AND  lg  GENE REARRANGEMENTS 
FIGURE 3.  Barn HI digestion and hybridization with J~ probe. Lane 1, DNA sample from 
patient 1 showed  an additional 16.0 kb band as well as the 18.0 kb germline band. Lanes 2- 
4, DNA samples from other patients; only the 18.0 kb germline band was detected. 
absent;  only  the  4  kb  band,  corresponding  to  C~  region,  was  detected.  This 
configuration is consistent with deletion of C~ regions from both loci. With the 
JC2 probe and Eco RI digestion, two rearranged bands, 6.0 kb and 5.5 kb, were 
present; the 4 kb germline band was absent (Fig. 2 c, lane 2). This configuration 
suggests rearrangement  into both C2 loci. 
Patient 2.  With Barn HI digestion and/3-C probe (Fig. 2a, lane 2), there is a 
single 27  kb rearranged  band.  Since the germline  band was not detected, and 
there  is  only  one  rearrangement  band,  this  configuration  is  consistent  with 
deletion of one/3-TCR locus and rearrangement  of the remaining locus. This is 
confirmed by Eco RI digestion. In this case, no germline 11 kb band was detected, 
a  rearranged  9  kb band was seen in addition  to the  4  kb germline  band.  This 
shows rearrangement  into C~ locus. 
Patient 3.  With Barn HI digestion and/3-C probe (Fig.  2a, lane  1) there is a 
single 23.5 kb band. With Eco RI digestion (Fig. 2b, lane  1), two bands,  11 and 
4 kb, respectively, were seen (Fig. 2 b, lane  i). The  11 kb band is less dense than 
the 4 kb band; this is consistent with deletion of one C1 locus. With the JC2 probe 
and Eco RI digestion, a 4 kb germline band and a rearranged  7.5 kb band were 
seen (Fig. 2c, lane I), confirming rearrangement  into one C2 locus with deletion 
of one C1 locus. 
Ig Rearrangement 
When digested with Barn HI and hybridized with ~P-labeled Ju probe, DNA 
samples from 23 of 24 patients showed a single germline  18.0 kb band.  (Fig.  3, 
lanes 2-4).  Patient  l's DNA showed an additional  16 kb band in addition to the 
18  kb  germline  band  (Fig.  3,  lane  1).  No  rearrangement  of the  ~ chain  was 
detected with the Ck probe in any patient's sample. 
Dot  blot  analysis.  RNA  samples  from  patient  1,  patient  2,  and  patient  3 
expressed a/3-TCR gene transcript (Fig. 4 a, lanes 3 and 4). 
Northern  blot  analysis.  RNA samples  from  patient  1 expressed  a  1.0  kb 13- 
TCR mRNA, while RNA from Jurkat cell line expressed the complete 1.3 kb/3- 
TCR gene transcript as well as the  1.0 kb transcript  (Fig. 4b). No g H  chain  Ig 
mRNA could be detected by Northern blot analysis (Fig. 4c). CHENG  ET  AL.  419 
FIGURE 4.  A, Dot blot analysis is shown of RNA from patients with T-ALL (lanes 1 and 2) 
patient  1 (lane 3),  patient  2  (lane  4),  expressed  3-TCR  gene  transcript.  No  transcript  was 
detected in RNA from a patient with B-CLL (lane 5).  Data from patient 3 was not shown. B, 
Northern Blot analysis is shown of RNA from the Jurkat cell line (T cell line) expressed  1.30 
kb 3-TCR gene transcript and an incomplete  1 kb message on Northern blot analysis.  RNA 
from patient 1 expressed an incomplete 1.0 kb message. No 3-TCR transcript was detected in 
RPMI-3638  (B cell line). C,  A  2.30  kb  Ig H  chain transcript  was  expressed  in  RPMI-3638 
RNA. RNA from Jurkat cell line and patient  1 did not express an Ig gene message transcript. 
Karyotypic Analysis 
The  karyotypes  of patient  1  and  patient  2  are  shown  in  Fig.  5,  a  and  b, 
respectively. 
In patient  1, a  46 XY,  7:12 transiocation  karyotype was found.  In patient  2, 
the cells were hypodiploid with consistent loss of chromosomes 7,  17, 22, and Y; 
a  1:5  translocation  and  three  marker  chromosomes  were  also  identified.  In 
patient 3, a karyotypic analysis was not done. 
Discussion 
Rearrangements  of Ig genes  are  generally  considered  to  be  lineage-specific 
events,  reflecting the commitment  of stem  cells to differentiation  along  the  B 
lymphocyte lineage.  Such rearrangements,  while common in cases of human  B 
cell malignancy, are a rare event in non-B cell neoplasia (29). Similarly, in T  cell 
malignancies, rearrangement  of the/3-TCR genes have been detected (15). 
In this study, we analyzed the organization  and expression of the Ig H  and L 
chain genes as well as the/3-TCR gene in 24 patients with a  diagnosis of AML. 
The blast cells from all these patients fulfilled the morphological and cytochem- 
ical criteria of AML by FAB classification.  Moreover, when studied with a panel FIGURE 5.  A, Karyotype of patient 1. There is a 7:12 translocation. B, Karyotype of patient 
2.  The cells are hypodiploid. There were consistent 1:5  translocations, deletions of Y chro- 
mosomes, and monosomies in 7,  17, 22. Three marker chromosomes were detected. 
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of immunological reagents, blast cells from these patients expressed one or more 
markers associated with the myeloid lineages. Cells from some of these patients 
simultaneously expressed markers of more than one myeloid lineage, (intralin- 
eage infidelity) or markers associated with both lymphoid and myeloid lineages 
(interlineage infidelity). Abnormalities of i3-TCR gene were seen in DNA samples 
from 3 of 24 patients; in addition, changes were found in Ig genes of patient 1. 
While other mechanisms (for example random deletion) cannot be excluded, the 
observations are most readily explained by gene rearrangement. It seems unlikely 
that three random events, affecting the leukemic population in different patients, 
would mimic the changes firmly associated with the rearrangements that occur 
during lymphopoiesis. The frequency of rearrangements in AML blasts detected 
here is a minimal estimate, since analysis with more probes and different restric- 
tion enzymes might detect further abnormalities. 
The rearranged configurations differed in these three patients, indicating that 
in myeloid leukemia, rearrangements of the 13-TCR or Ig genes may have the 
same diverse pattern as in lymphoid malignancies (14). On Northern blot analysis, 
patient  1  RNA  expressed  an  incomplete  1.0  kb  /3-TCR  transcript,  which  is 
reminiscent of the joining of the D, J, and C regions of the/3-TCR gene (DJC 
transcript)  (30),  or a JC  transcript  (31);  no  Ig  H  chain  mRNA was  detected 
despite a rearranged JH band. These findings suggested that, at least in myeloid 
leukemia, rearrangement of the /3-TCR or Ig gene loci does not always imply 
expression of a  functional mRNA transcript. This is supported by the absence 
of T  cell surface antigens or surface or cytoplasmic Ig in this patient's blast cells. 
In contrast, in patient  2,  T  cell-associated markers were found on occasional 
blast cells. 
DNA samples from two patients showed only the rearranged configuration. 
These data are consistent with the view that the individual patient's leukemic 
cells  had  the  same  gene  rearrangements and  therefore were  clonal,  despite 
considerable heterogeneity in  surface phenotypes.  It  follows that  the  genetic 
markers associated with lymphoid differentiation were present in the same cells 
that express phenotypic markers associated with granulopoiesis. In patient 3, an 
apparent germline configuration was detected with the 13-C probe and Bam HI 
digestion, but rearrangement into the C2 locus was demonstrated with JC2 probe 
following Eco RI digestion. These molecular findings for patient 3, while com- 
patible  with a  single clonal population,  cannot be considered as conclusive as 
those  for  the  previous  two  patients,  since  the  normal  bands  evident  in  the 
Southern blots could be derived for a second coexisting population. 
Cytogenetic analysis revealed abnormal karyotypes in two patients with rear- 
rangement of/3-TCR gene. Patient 1 showed a 7:12 translocation, while patient 
2's blast cells were hypodiploid, with 1:5 translocation, deletion of chromosomes 
7,  17,  22, and Y, as well as three additional marker chromosomes. The/3-TCR 
gene is located on band q35 of chromosome 7 (32) and the karyotypes of both of 
these patients  showed an abnormality involving chromosome 7;  however, the 
breakpoint in patient  1 is distant from the/3-TCR gene locus. In patient 2, the 
rearranged DNA configuration suggested deletion of one /3-TCR  locus, this is 
consistent with the loss of one chromosome 7. 
The significance of 13-TCR or Ig gene rearrangement in  myeloid leukemia 422  T  CELL  RECEPTOR  AND  Ig  GENE  REARRANGEMENTS 
remains  to  be  determined.  The  restriction  patterns  observed  in  at  least  two 
patients provide evidence that the disease was clonai; therefore in these instances 
the coexistence of two clones, as reported  recently by Siegelman  et al.  (33) in 
lymphoma, is not a probable basis for the findings. Rather, events within a single 
leukemic clone require explanation.  Stem cell phenotypes and their patterns of 
predeterministic differentiation are not known. It is possible, therefore, that the 
association of fl-TCR and Ig gene rearrangements  with predeterministic  myelo- 
poiesis  may  not  be  abnormal.  This  view  is  supported  by our  failure  to  find 
complete VDJ joining. 
The restriction enzyme patterns are consistent with DJ joining,  an event that 
might  occur  without  leading  to  lineage  commitment.  It  is  also  possible  that 
leukemic transformation  itself may be able to confer myelopoietic specificity on 
stem cells that have already undergone some gene rearrangement.  Nonetheless, 
our findings  are  consistent  with  the  concept of lineage  infidelity.  Indeed,  the 
hypothesis of abnormal  gene expression  in  leukemia predicts that  unusual  mo- 
lecular configurations will be encountered.  There are now numerous examples 
of mutations,  gene  amplifications,  and  rearrangements  in  leukemia  (34-36). 
Further direct studies of gene expression are needed if these molecular findings 
are to be related unequivocally to leukemic patterns of growth and maturation. 
Summary 
The  organization  and  expression  of the  /3 chain  of T  cell  antigen  receptor 
gene  (/3-TCR)  and  Ig  H  and  L  chain  genes  were analyzed  by Southern  blot 
technique in 24 patients with a diagnosis of acute myeloblastic leukemia (AML). 
Rearrangements  of the/3-TCR genes were seen in DNA samples from 3 of the 
24 patients.  One of these three patients also showed rearrangement  of the Ig H 
chain  gene.  RNA  samples  from  all  three  patients  expressed  a  /3-TCR  gene 
transcript on dot blot analysis.  However, on Northern blot analysis, one patient 
expressed an incomplete  1.0 kb transcript and no Ig H  chain mRNA, despite a 
rearranged  configuration.  The  karyotypes  of two  of  these  patients  showed 
abnormalities involving chromosome 7. Rearrangements ofT cell antigen recep- 
tor  genes  may  occur  in  nonlymphoid  malignancy,  and  is  consistent  with  the 
concept of lineage infidelity in AML. 
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